0001873722 2026-01-01 2026-06-30 0001873722 dei:FormerAddressMember 2026-01-01 2026-06-30 0001873722 2026-08-21 0001873722 2026-06-30 0001873722 2025-12-31 0001873722 us-gaap:SeriesCPreferredStockMember 2026-06-30 0001873722 us-gaap:SeriesCPreferredStockMember 2025-12-31 0001873722 2026-04-01 2026-06-30 0001873722 2025-04-01 2025-06-30 0001873722 2025-01-01 2025-06-30 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2024-12-31 0001873722 us-gaap:CommonStockMember 2024-12-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001873722 us-gaap:RetainedEarningsMember 2024-12-31 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001873722 2024-12-31 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2025-03-31 0001873722 us-gaap:CommonStockMember 2025-03-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001873722 us-gaap:RetainedEarningsMember 2025-03-31 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001873722 2025-03-31 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2025-12-31 0001873722 us-gaap:CommonStockMember 2025-12-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001873722 us-gaap:RetainedEarningsMember 2025-12-31 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2026-03-31 0001873722 us-gaap:CommonStockMember 2026-03-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001873722 us-gaap:RetainedEarningsMember 2026-03-31 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001873722 2026-03-31 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-03-31 0001873722 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001873722 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001873722 2025-01-01 2025-03-31 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2025-01-01 2025-06-30 0001873722 us-gaap:CommonStockMember 2025-01-01 2025-06-30 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001873722 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001873722 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-04-01 2025-06-30 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2026-01-01 2026-03-31 0001873722 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001873722 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001873722 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001873722 2026-01-01 2026-03-31 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001873722 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001873722 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-04-01 2026-06-30 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2025-06-30 0001873722 us-gaap:CommonStockMember 2025-06-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001873722 us-gaap:RetainedEarningsMember 2025-06-30 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-06-30 0001873722 2025-06-30 0001873722 us-gaap:SeriesCPreferredStockMember us-gaap:PreferredStockMember 2026-06-30 0001873722 us-gaap:CommonStockMember 2026-06-30 0001873722 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001873722 us-gaap:RetainedEarningsMember 2026-06-30 0001873722 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-06-30 0001873722 us-gaap:ConvertibleDebtMember 2026-06-30 0001873722

us-gaap:GeneralAndAdministrativeExpense

2026-04-01 2026-06-30 0001873722

us-gaap:GeneralAndAdministrativeExpense

2026-01-01 2026-06-30 0001873722 us-gaap:SeriesCPreferredStockMember 2026-01-01 2026-06-30 0001873722 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-06-30 0001873722 us-gaap:WarrantMember 2026-01-01 2026-06-30 0001873722 us-gaap:WarrantMember 2025-01-01 2025-06-30 0001873722 2025-01-01 2025-12-31 0001873722 srt:NorthAmericaMember 2026-01-01 2026-06-30 0001873722 srt:NorthAmericaMember 2025-01-01 2025-06-30 0001873722 srt:EuropeMember 2026-01-01 2026-06-30 0001873722 srt:EuropeMember 2025-01-01 2025-06-30 0001873722 srt:NorthAmericaMember 2026-06-30 0001873722 srt:NorthAmericaMember 2025-12-31 0001873722 srt:EuropeMember 2026-06-30 0001873722 srt:EuropeMember 2025-12-31 0001873722 us-gaap:IntellectualPropertyMember 2026-06-30 0001873722 us-gaap:IntellectualPropertyMember 2025-12-31 0001873722 us-gaap:PatentsMember 2026-06-30 0001873722 us-gaap:PatentsMember 2025-12-31 0001873722 BBLR:CapitalizedAcquisitionCostsMember 2026-06-30 0001873722 BBLR:CapitalizedAcquisitionCostsMember 2025-12-31 0001873722 us-gaap:InvestorMember 2025-04-04 2025-04-04 0001873722 us-gaap:InvestorMember 2025-07-15 2025-07-15 0001873722 2025-01-01 0001873722 2026-01-01 0001873722 2025-10-08 2025-10-09 0001873722 BBLR:StaffAccountingBulletinMember 2026-01-01 2026-06-30 0001873722 BBLR:StaffAccountingBulletinMember 2025-01-01 2025-12-31 0001873722 BBLR:StaffAccountingBulletinMember 2026-01-01 2026-03-31 0001873722 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001873722 us-gaap:FairValueInputsLevel3Member 2024-12-31 0001873722 us-gaap:FairValueInputsLevel3Member 2026-01-01 2026-06-30 0001873722 us-gaap:FairValueInputsLevel3Member 2025-01-01 2025-12-31 0001873722 us-gaap:FairValueInputsLevel3Member 2026-06-30 0001873722 us-gaap:RelatedPartyMember 2026-01-01 2026-06-30 0001873722 BBLR:LoanOneMember BBLR:StephenMorrisMember 2025-12-31 0001873722 BBLR:LoanOneMember BBLR:StephenMorrisMember 2024-12-31 0001873722 BBLR:LoanOneMember BBLR:StephenMorrisMember 2026-01-01 2026-06-30 0001873722 BBLR:LoanOneMember BBLR:StephenMorrisMember 2025-01-01 2025-12-31 0001873722 BBLR:LoanOneMember BBLR:StephenMorrisMember 2026-06-30 0001873722 BBLR:StephenMorrisMember 2026-06-30 0001873722 BBLR:StephenMorrisMember 2025-12-31 0001873722 us-gaap:RelatedPartyMember 2026-06-30 0001873722 us-gaap:RelatedPartyMember 2025-12-31 0001873722 BBLR:StephenMorrisMember BBLR:SixthAmendmentMember 2024-09-30 2024-09-30 0001873722 BBLR:StephenMorrisMember BBLR:LoanAgreementMember 2022-09-07 0001873722 srt:MinimumMember us-gaap:MeasurementInputExpectedTermMember 2026-06-30 0001873722 srt:MaximumMember us-gaap:MeasurementInputExpectedTermMember 2026-06-30 0001873722 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2026-06-30 0001873722 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2026-06-30 0001873722 us-gaap:MeasurementInputExpectedDividendRateMember 2026-06-30 0001873722 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-30 0001873722 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-30 0001873722 us-gaap:SeriesCPreferredStockMember 2023-03-04 0001873722 us-gaap:SeriesCPreferredStockMember 2023-03-04 2023-03-04 0001873722 us-gaap:SeriesCPreferredStockMember 2025-01-01 2025-12-31 0001873722 BBLR:SeriesCConvertiblePreferredStockMember 2025-01-01 2025-12-31 0001873722 us-gaap:ConvertibleCommonStockMember 2026-04-01 2026-06-30 0001873722 us-gaap:ConvertibleCommonStockMember 2026-01-01 2026-06-30 0001873722 us-gaap:WarrantMember 2026-06-30 0001873722 BBLR:EquityIncentivePlanMember 2022-05-24 2022-05-25 0001873722 2025-01-14 2025-01-14 0001873722 BBLR:TwoThousadTwentyFiveEmployeeAndConsultantStockPlanMember 2025-04-04 2025-04-04 0001873722 srt:ExecutiveOfficerMember BBLR:EquityIncentivePlanMember 2025-04-15 2025-04-15 0001873722 BBLR:ConsultantsMember BBLR:TwoThousadTwentyFiveEmployeeAndConsultantStockPlanMember 2025-05-20 2025-05-20 0001873722 BBLR:EmployeeMember BBLR:EquityIncentivePlanMember 2025-06-11 2025-06-11 0001873722 2025-06-11 2025-06-11 0001873722 2025-06-13 2025-06-13 0001873722 BBLR:SixConsultantsMember 2025-06-19 2025-06-19 0001873722 BBLR:ExecutiveMember 2025-11-05 2025-11-05 0001873722 BBLR:NonExecutiveMember 2025-11-18 2025-11-18 0001873722 2025-04-16 2025-04-16 0001873722 2024-01-01 2024-12-31 0001873722 BBLR:WarrantsOneMember 2026-06-30 0001873722 BBLR:WarrantsOneMember 2026-01-01 2026-06-30 0001873722 BBLR:WarrantsTwoMember 2026-06-30 0001873722 BBLR:WarrantsTwoMember 2026-01-01 2026-06-30 0001873722 BBLR:WarrantsThreeMember 2026-06-30 0001873722 BBLR:WarrantsThreeMember 2026-01-01 2026-06-30 0001873722 BBLR:WarrantsFourMember 2026-06-30 0001873722 BBLR:WarrantsFourMember 2026-01-01 2026-06-30 0001873722 BBLR:WarrantsFiveMember 2026-06-30 0001873722 BBLR:WarrantsFiveMember 2026-01-01 2026-06-30 0001873722 srt:MinimumMember 2026-01-01 2026-06-30 0001873722 srt:MaximumMember 2026-01-01 2026-06-30 0001873722 srt:MinimumMember 2025-01-01 2025-12-31 0001873722 srt:MaximumMember 2025-01-01 2025-12-31 0001873722 srt:MaximumMember BBLR:StephenMorrisMember BBLR:SecondAmendedEmploymentAgreementMember 2023-01-01 2023-12-31 0001873722 srt:MinimumMember BBLR:StephenMorrisMember BBLR:SecondAmendedEmploymentAgreementMember 2023-01-01 2023-12-31 0001873722 BBLR:StephenMorrisMember BBLR:SecondAmendedEmploymentAgreementMember 2023-01-01 2023-12-31 0001873722 BBLR:StephenMorrisMember BBLR:SecondAmendedEmploymentAgreementMember 2023-12-31 0001873722 srt:MaximumMember BBLR:DavidChetwoodMember BBLR:SecondAmendedEmploymentAgreementMember 2023-01-01 2023-12-31 0001873722 srt:MinimumMember BBLR:DavidChetwoodMember BBLR:SecondAmendedEmploymentAgreementMember 2023-01-01 2023-12-31 0001873722 BBLR:DavidChetwoodMember BBLR:SecondAmendedEmploymentAgreementMember 2023-01-01 2023-12-31 0001873722 srt:MaximumMember BBLR:DavidChetwoodMember BBLR:ThirdAmendedEmploymentAgreementMember 2024-10-17 0001873722 srt:MinimumMember BBLR:DavidChetwoodMember BBLR:ThirdAmendedEmploymentAgreementMember 2024-10-17 0001873722 BBLR:DavidChetwoodMember BBLR:ThirdAmendedEmploymentAgreementMember 2024-10-17 0001873722 BBLR:MrPatrickEnsorMember BBLR:EmploymentAgreementMember 2025-08-05 2025-08-05 0001873722 BBLR:MrPatrickEnsorMember BBLR:EmploymentAgreementMember 2025-08-05 0001873722 BBLR:ManfredEbensbergerMember BBLR:ExecutiveConsultingAgreementMember 2024-10-17 2024-10-17 0001873722 BBLR:ManfredEbensbergerMember BBLR:ExecutiveConsultingAgreementMember 2024-10-17 0001873722 BBLR:TomSymondsMember BBLR:ExecutiveConsultingAgreementMember 2025-01-15 2025-01-15 0001873722 us-gaap:CommonStockMember us-gaap:SubsequentEventMember 2026-07-02 2026-07-02 0001873722 us-gaap:SubsequentEventMember 2026-07-02 2026-07-02 0001873722 us-gaap:SubsequentEventMember 2026-07-06 2026-07-06 0001873722 BBLR:PromissoryNoteMember us-gaap:SubsequentEventMember 2026-07-22 2026-07-22 0001873722 BBLR:PromissoryNoteOneMember us-gaap:SubsequentEventMember 2026-07-22 2026-07-22 iso4217:USD shares iso4217:USD shares pure iso4217:EUR BBLR:Segment false --12-31 Q2 0001873722

10-Q true 2026-06-30 2026 false 333-260902 Bubblr, Inc. WY 86-2355916 30 N. Gould St. #20629 Sheridan WY 82801 (646) 814-7184 30 N. Gould St. Suite R Sheridan WY 82801 Yes Yes Non-accelerated Filer true true false false 305309155 0.01

335

7322

520

2039

6305

9110

7160

18471

1123157

1262933

1123157

1262933

1130317

1281404

398995

368444

1308514

1233502

1007599

836382

241656

212102

479865

197365

3366231

2918193

1228920

1253210

231

1228920

1253441

4595151

4171634

0.001

2000

783

0.01

3000000000

250331008

177588785

2503310

1775888

12439222

13178116

-18714187

-18131202

306820

286967

-3464834

-2890230

1130317

1281404

712

469

1353

100

612

469

1253

-17970

147028

118888

312050

40249

13567

62154

30347

1875

71460

6225

85798

64167

55394

128628

109348

92282

64547

164041

120932

180603

351996

479936

658475

-180570

-351384

-479467

-657222

-191

105300

387

411734

4017

446680

4017

2279

72177

-60542

214743 -16358 370206 10853

-445

-12

-377

-259991

-20820

-103518

6462

-440561

-372204

-582985

-650760

-440561

-372204

-582985

-650760

1262

-80801

19853

-95888

1262

-80801

19853

-95888

-439299

-453005

-563132

-746648

0.00

225610333

170860597

204107280

168360597

903

159890447

1598904

13090218

-17012492

367385

-1955984

-80

5970150

59702

-59702

40887

-21672 -21672

-278556

-15087

823

165860597

1658606

13071403

-17312720

352298

-2230412

-19

7500000

75000

-75000

177757

173376 173376

-372204

-80801

804

173360597

1733606

13174160

-17511548

271497

-2332284

783

177588785

1775888

13178116

-18131202

286967

-2890230

1007

14270702

142707

-112707

30000

-142424

18591

783

191859487

1918595

13066416

-18273626

305558

-2983056

1029

144148

58471521

584715

-484075

100640

-440561

1262

783

250331008

2503310

12439222

-18714187

306820

-3464834

-582985

-650760

-2036 -218644 144148

-72177

372779

10500

-60542

370206 10853

128628

109348

-1508

714

-2805

33199

59614

84342

88097

123904

114005

-204919

-72619

6439

157132

-6439

-157132

170987

173563

59561

59137

22151

4727

203670

232700

701

-40029

-6987

-37080

7322

41184

335

4104

6883

151704 130640 197365

<p id="xdx_809_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zyBg5JX6NX99" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY Organization and Operations On December 18, 2019, U.S. Wireless Online, Inc. (“UWRL”), a Wyoming corporation established on May 4, 1998, UWRL Acquisition Inc., and Bubblr Holdings Limited, a company incorporated under the laws of the United Kingdom on December 6, 2016, entered into an Agreement and Plan of Merger. On March 26, 2020, the transaction was completed, whereby UWRL Acquisition Inc. merged with and into Bubblr Holdings Limited, with Bubblr Holdings Limited surviving as a wholly owned subsidiary of U.S. Wireless Online, Inc. Subsequently, on March 30, 2021, U.S. Wireless Online, Inc. formally changed its corporate name to Bubblr, Inc. (the “Company”). The Company, doing business as Ethical Web AI (“EW”), is an artificial intelligence (“AI”) corporation focused on advancing its patented intellectual property portfolio. Following an extended period of technical development, the Company is pivoting toward commercialization and commencing its revenue growth phase, driven by the rollout of its first enterprise platform product, AI Vault. Going Concern Matters The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”), which contemplate the Company’s continuation as a going concern. The Company incurred a net comprehensive loss of $563,132 during the six months ended June 30, 2026, and had an accumulated deficit of $18,714,187 as of that date. In addition, the Company maintained a working capital deficit of $3,359,071 as of June 30, 2026, as current liabilities exceeded current assets. Management intends to secure necessary operating funds through equity or debt offerings; however, the success of these capital-raising endeavors cannot be guaranteed. There are no assurances that the Company will be able to attain a revenue level sufficient to generate positive cash flow from operations, or secure additional financing through private placements, public offerings, or debt instruments to satisfy its short-term working capital requirements. If funds from operations or external capital sources prove insufficient, the Company will be required to explore alternative and potentially restrictive sources of working capital. No guarantee exists that such financing will be available to the Company, or if available, on commercially acceptable terms. Failure to obtain sufficient working capital within the required timeframe will compel the Company to reduce, restructure, or cease operations. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued. The accompanying consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, nor the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

-563132

-18714187

-3359071

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments—consisting of normal recurring accruals—considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2026, are not necessarily indicative of the results that may be expected for the year ending December 31, 2026. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances, transactions, and unrealized gains or losses have been eliminated in consolidation. Reclassification During the current reporting period, the Company reviewed the nature and substance of certain balances previously presented within Accounts Payable and Accrued Liabilities. As a result of this review, amounts relating to transactions with related parties were identified and determined to be more appropriately classified as Due to Related Parties. Accordingly, comparative figures have been reclassified to conform to the current period’s presentation. During the six months ended June 30, 2025, the Company reviewed the nature and substance of certain balances previously presented within Operating Expenses. As a result of this review, amounts relating to transactions in Sales and Marketing were identified and determined to be more appropriately classified as Professional fees. This reclassification has been made to better reflect the underlying nature of these balances and to enhance the usefulness and transparency of the financial statements. The reclassification had no impact on total assets, total liabilities, shareholders’ equity, or net income for the periods presented. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Intangible Assets - Capitalized Product Development Costs Accounting Standards Codification (“ASC”) Topic 350-40, “Internal-Use Software,” applies to software developed for internal use or to provide a service, where the customer does not acquire a contractual right to take possession of the software. Our products incorporate embedded software developed internally by Bubblr, a critical component that facilitates communication among components. The product’s functionality depends on this software. Expenditures associated with product development are capitalized until technological feasibility is achieved. Such costs encompass subcontractor fees, personnel wages, and other related expenses incurred during the development phase. The Company considers technological feasibility achieved once all high-risk development challenges have been addressed. Upon the product’s availability for general release to the Company’s customers, the Company discontinues capitalizing development costs, and any additional expenses incurred thereafter are recognized as expenses. The capitalized costs are amortized on a straight-line basis. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or its useful life is no longer appropriate. Recoverability is assessed by comparing the carrying amount of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount exceeds the undiscounted cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the asset’s estimated fair value. Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if specific criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company uses the Black-Scholes options pricing model to estimate the value of its derivative liabilities and to measure them at the end of each reporting period. Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures,” which establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data. Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying amounts of the Company’s financial instruments, including cash, other receivables, accounts payable, accrued liabilities, and amounts due to related parties, approximate their fair value due to the short-term nature of these instruments. The warrant derivative liabilities and convertible debt derivative liability are Level 3 financial instruments measured at fair value on a recurring basis. The Company utilizes the Black-Scholes option-pricing model to estimate the fair value of these derivatives. As of June 30, 2026, the fair value of the warrant liabilities was $0, and the convertible debt derivative liability was $212,102. There were no changes to the fair value hierarchy during the six months ended June 30, 2026, or 2025. Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement, net-share settlement, or (2) give the Company a choice of net-cash settlement or settlement in its shares (either physical or net-share). Contracts that (1) require net-cash settlement (including cases where the contract must be settled in cash if an event occurs outside the Company’s control), (2) provide the counterparty with a choice between net-cash settlement or settlement in shares (physical or net-share), or (3) contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company evaluates the classification of its common stock purchase warrants and other derivatives at each reporting date to determine if a change from liabilities to equity is necessary. Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation—Stock Compensation,” which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expenses in the consolidated financial statements based on the stock awards’ fair values on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (typically the vesting period). In accordance with ASC 718, cumulative compensation expenses previously recognized for these unvested awards in prior periods are credited back to the general and administrative expense line item in the period of forfeiture. During the three and six-month period ended June 30, 2026, general and administrative expenses include a $<span id="xdx_906_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20260401__20260630__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--GeneralAndAdministrativeExpense_zxAQEbIvrUp4" title="Share based compensation"><span id="xdx_90C_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20260101__20260630__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--GeneralAndAdministrativeExpense_zEvtI8MlOZ9j" title="Share based compensation">144,148 credit recorded within general administration resulting from these forfeitures. Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share are the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. <p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zH1tQdMyUweb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">For the six months ended June 30, 2026, and 2025, the following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260101__20260630_zV6La9JIVj0b" style="text-align: center">2026</td><td> </td><td> </td> <td colspan="2" id="xdx_492_20250101__20250630_zHSBZipJRgC3" style="text-align: center">2025</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">2026</td><td> </td><td> </td> <td colspan="2" style="text-align: center">2025</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Shares)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Shares)</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zWtCWDauBuaf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Series C Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">2,934,416</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">3,265,335</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zBD9Q94qHbNf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,538,101</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,259,837</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Equity Incentive Plan Awards</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,618,750</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,255,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zuLD4x6TNTYg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27,091,267</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">28,780,172</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zqK1WdBrCxN9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Anti-dilutive shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27,091,267</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">28,780,172</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount it believes is more likely than not to be realized. As of June 30, 2026, and 2025, the Company did not have any amounts recorded for uncertain tax positions. Foreign Currency Translations The functional currency of the Company’s international subsidiaries is the British pound (GBP). Local currency assets and liabilities are translated at the exchange rates as of the balance sheet date, and local currency revenues and expenses are translated at the weighted average exchange rate for the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. <p id="xdx_894_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zOzjdAZsYqX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260401__20260630_zvACDo67J7Bh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250401__20250630_zCnRCzhtWxma" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td> </td> <td id="xdx_49B_20260101__20260630_z1nI4OKKJSF6" style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_49D_20250101__20250630_z1byUfa0FtH7" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_499_20250101__20251231_zBaToarwBzjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026 </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_ecustom--ForeignCurrencyExchangeRateTranslation_zLJ25MqgaF8d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Period-end GBP£: U.S.$ exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3261</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3779</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 9%">1.3261</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 9%">1.3779</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3472</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--DerivativeAverageForwardExchangeRate_zHlUQMbKzD84" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted average GBP£: U.S.$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3357</td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right">1.3455</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.2979</td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3188</td><td style="text-align: left"> </td></tr> </table> Segment Reporting Accounting Standards Codification (“ASC”) 280, “Segment Reporting,” requires public companies to report financial and descriptive information about their reportable operating segments. The Company identifies operating segments based on how our Chief Financial Officer evaluates separate financial information, business activities, and management responsibilities. Accordingly, the Company has one reportable segment, consisting of fees for App usage. SCHEDULE OF SEGMENT REPORTING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Net sales:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20260101__20260630_zgJVBWPUrXK2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20250101__20250630_zMzlMLOiIiL5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Net sales:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z9fO4Xzp2O7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">436</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,353</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__srt--EuropeMember_zwGfnxsDb1P5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">33</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_zxWv9uRSzo3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Totals</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">469</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,353</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--Revenues_z8QbGfAOXATj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Net sales</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">469</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,353</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Long-lived assets, net (property and equipment and intangible assets):</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260630_z27247W8XgI1" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20251231_zMxTJjulRVw1" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_zL4DnIguTxi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">33,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">34,305</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_hsrt--StatementGeographicalAxis__srt--EuropeMember_zMADUHVEPcL4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,089,996</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,228,628</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zEzzJiPp9DN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Totals</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,123,157</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,262,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zb4mDSlKAup9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Long-lived assets, net (property and equipment and intangible assets)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,123,157</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,262,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> Recent Accounting Pronouncements The Company has reviewed all recently issued. In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (“ASU 2024 03”), and in January 2025, the FASB issued ASU No. 2025-01, Clarifying the Effective Date (“ASU 2025-01”). The amendments are intended to enhance disclosures regarding an entity’s costs and expenses by requiring additional disaggregated information disclosures about certain income statement expense line items. The amendments, as clarified by ASU 2025-01, are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is evaluating the effect of adopting the new disclosure requirements. In September 2025, the FASB issued ASU No. 2025-06, Targeted Improvements to the Accounting for Internal-Use Software (“ASU 2025-06”). The amendments are intended to clarify and modernize the accounting for costs related to internal-use software. The guidance removes all references to project stages and clarifies the threshold entities apply to begin capitalizing costs. The amendments are effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years, with early adoption permitted. The Company does not expect the adoption to have a material impact on the Company’s financial statements.

Basis of Presentation The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments—consisting of normal recurring accruals—considered necessary for a fair presentation have been included. Operating results for the three and six months ended June 30, 2026, are not necessarily indicative of the results that may be expected for the year ending December 31, 2026.

Principles of Consolidation The consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances, transactions, and unrealized gains or losses have been eliminated in consolidation.

Reclassification During the current reporting period, the Company reviewed the nature and substance of certain balances previously presented within Accounts Payable and Accrued Liabilities. As a result of this review, amounts relating to transactions with related parties were identified and determined to be more appropriately classified as Due to Related Parties. Accordingly, comparative figures have been reclassified to conform to the current period’s presentation. During the six months ended June 30, 2025, the Company reviewed the nature and substance of certain balances previously presented within Operating Expenses. As a result of this review, amounts relating to transactions in Sales and Marketing were identified and determined to be more appropriately classified as Professional fees. This reclassification has been made to better reflect the underlying nature of these balances and to enhance the usefulness and transparency of the financial statements. The reclassification had no impact on total assets, total liabilities, shareholders’ equity, or net income for the periods presented.

Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates.

Intangible Assets - Capitalized Product Development Costs Accounting Standards Codification (“ASC”) Topic 350-40, “Internal-Use Software,” applies to software developed for internal use or to provide a service, where the customer does not acquire a contractual right to take possession of the software. Our products incorporate embedded software developed internally by Bubblr, a critical component that facilitates communication among components. The product’s functionality depends on this software. Expenditures associated with product development are capitalized until technological feasibility is achieved. Such costs encompass subcontractor fees, personnel wages, and other related expenses incurred during the development phase. The Company considers technological feasibility achieved once all high-risk development challenges have been addressed. Upon the product’s availability for general release to the Company’s customers, the Company discontinues capitalizing development costs, and any additional expenses incurred thereafter are recognized as expenses. The capitalized costs are amortized on a straight-line basis.

Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable or its useful life is no longer appropriate. Recoverability is assessed by comparing the carrying amount of the asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount exceeds the undiscounted cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the asset’s estimated fair value. Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if specific criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. The Company uses the Black-Scholes options pricing model to estimate the value of its derivative liabilities and to measure them at the end of each reporting period.

Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures,” which establishes a fair value hierarchy that prioritizes the inputs used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data. Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying amounts of the Company’s financial instruments, including cash, other receivables, accounts payable, accrued liabilities, and amounts due to related parties, approximate their fair value due to the short-term nature of these instruments. The warrant derivative liabilities and convertible debt derivative liability are Level 3 financial instruments measured at fair value on a recurring basis. The Company utilizes the Black-Scholes option-pricing model to estimate the fair value of these derivatives. As of June 30, 2026, the fair value of the warrant liabilities was $0, and the convertible debt derivative liability was $212,102. There were no changes to the fair value hierarchy during the six months ended June 30, 2026, or 2025.

212102

Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement, net-share settlement, or (2) give the Company a choice of net-cash settlement or settlement in its shares (either physical or net-share). Contracts that (1) require net-cash settlement (including cases where the contract must be settled in cash if an event occurs outside the Company’s control), (2) provide the counterparty with a choice between net-cash settlement or settlement in shares (physical or net-share), or (3) contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company evaluates the classification of its common stock purchase warrants and other derivatives at each reporting date to determine if a change from liabilities to equity is necessary.

Stock-Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation—Stock Compensation,” which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expenses in the consolidated financial statements based on the stock awards’ fair values on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (typically the vesting period). In accordance with ASC 718, cumulative compensation expenses previously recognized for these unvested awards in prior periods are credited back to the general and administrative expense line item in the period of forfeiture. During the three and six-month period ended June 30, 2026, general and administrative expenses include a $<span id="xdx_906_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20260401__20260630__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--GeneralAndAdministrativeExpense_zxAQEbIvrUp4" title="Share based compensation"><span id="xdx_90C_eus-gaap--EmployeeBenefitsAndShareBasedCompensation_c20260101__20260630__us-gaap--StatementOfIncomeLocationBalanceAxis__us-gaap--GeneralAndAdministrativeExpense_zEvtI8MlOZ9j" title="Share based compensation">144,148 credit recorded within general administration resulting from these forfeitures.

144148

Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share are the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. <p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zH1tQdMyUweb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">For the six months ended June 30, 2026, and 2025, the following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260101__20260630_zV6La9JIVj0b" style="text-align: center">2026</td><td> </td><td> </td> <td colspan="2" id="xdx_492_20250101__20250630_zHSBZipJRgC3" style="text-align: center">2025</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">2026</td><td> </td><td> </td> <td colspan="2" style="text-align: center">2025</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Shares)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Shares)</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zWtCWDauBuaf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Series C Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">2,934,416</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">3,265,335</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zBD9Q94qHbNf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,538,101</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,259,837</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Equity Incentive Plan Awards</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,618,750</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,255,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zuLD4x6TNTYg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27,091,267</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">28,780,172</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zqK1WdBrCxN9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Anti-dilutive shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27,091,267</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">28,780,172</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<p id="xdx_893_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zH1tQdMyUweb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">For the six months ended June 30, 2026, and 2025, the following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" id="xdx_491_20260101__20260630_zV6La9JIVj0b" style="text-align: center">2026</td><td> </td><td> </td> <td colspan="2" id="xdx_492_20250101__20250630_zHSBZipJRgC3" style="text-align: center">2025</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">June 30,</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">2026</td><td> </td><td> </td> <td colspan="2" style="text-align: center">2025</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Shares)</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(Shares)</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_402_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--SeriesCPreferredStockMember_zWtCWDauBuaf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Series C Preferred Stock</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">2,934,416</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right">3,265,335</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zBD9Q94qHbNf" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Warrants</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,538,101</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">2,259,837</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Equity Incentive Plan Awards</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">21,618,750</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">23,255,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zuLD4x6TNTYg" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27,091,267</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">28,780,172</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_zqK1WdBrCxN9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Anti-dilutive shares</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">27,091,267</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">28,780,172</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2934416

3265335

2538101

2259837

27091267

28780172

27091267

28780172

Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount it believes is more likely than not to be realized. As of June 30, 2026, and 2025, the Company did not have any amounts recorded for uncertain tax positions.

Foreign Currency Translations The functional currency of the Company’s international subsidiaries is the British pound (GBP). Local currency assets and liabilities are translated at the exchange rates as of the balance sheet date, and local currency revenues and expenses are translated at the weighted average exchange rate for the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. <p id="xdx_894_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zOzjdAZsYqX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260401__20260630_zvACDo67J7Bh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250401__20250630_zCnRCzhtWxma" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td> </td> <td id="xdx_49B_20260101__20260630_z1nI4OKKJSF6" style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_49D_20250101__20250630_z1byUfa0FtH7" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_499_20250101__20251231_zBaToarwBzjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026 </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_ecustom--ForeignCurrencyExchangeRateTranslation_zLJ25MqgaF8d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Period-end GBP£: U.S.$ exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3261</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3779</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 9%">1.3261</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 9%">1.3779</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3472</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--DerivativeAverageForwardExchangeRate_zHlUQMbKzD84" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted average GBP£: U.S.$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3357</td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right">1.3455</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.2979</td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3188</td><td style="text-align: left"> </td></tr> </table>

<p id="xdx_894_eus-gaap--ScheduleOfDifferencesBetweenReportedAmountAndReportingCurrencyDenominatedAmountTableTextBlock_zOzjdAZsYqX3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49E_20260401__20260630_zvACDo67J7Bh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_498_20250401__20250630_zCnRCzhtWxma" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td> </td> <td id="xdx_49B_20260101__20260630_z1nI4OKKJSF6" style="text-align: right"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_49D_20250101__20250630_z1byUfa0FtH7" style="text-align: right"> </td> <td> </td> <td> </td> <td colspan="2" id="xdx_499_20250101__20251231_zBaToarwBzjg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Three Months Ended June 30,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Six Months Ended June 30, </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2026 </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td style="padding-bottom: 1pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_ecustom--ForeignCurrencyExchangeRateTranslation_zLJ25MqgaF8d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 35%; text-align: left">Period-end GBP£: U.S.$ exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3261</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3779</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 9%">1.3261</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%"> </td> <td style="text-align: right; width: 9%">1.3779</td> <td style="width: 1%"> </td> <td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">1.3472</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--DerivativeAverageForwardExchangeRate_zHlUQMbKzD84" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Weighted average GBP£: U.S.$ exchange rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3441</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3357</td><td style="text-align: left"> </td><td> </td> <td> </td> <td style="text-align: right">1.3455</td> <td> </td> <td> </td> <td> </td> <td style="text-align: right">1.2979</td> <td> </td> <td> </td> <td style="text-align: left"> </td><td style="text-align: right">1.3188</td><td style="text-align: left"> </td></tr> </table>

1.3261 1.3779 1.3261 1.3779 1.3472 1.3441 1.3357 1.3455 1.2979 1.3188

Segment Reporting Accounting Standards Codification (“ASC”) 280, “Segment Reporting,” requires public companies to report financial and descriptive information about their reportable operating segments. The Company identifies operating segments based on how our Chief Financial Officer evaluates separate financial information, business activities, and management responsibilities. Accordingly, the Company has one reportable segment, consisting of fees for App usage. SCHEDULE OF SEGMENT REPORTING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Net sales:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20260101__20260630_zgJVBWPUrXK2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20250101__20250630_zMzlMLOiIiL5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Net sales:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z9fO4Xzp2O7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">436</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,353</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__srt--EuropeMember_zwGfnxsDb1P5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">33</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_zxWv9uRSzo3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Totals</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">469</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,353</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--Revenues_z8QbGfAOXATj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Net sales</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">469</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,353</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Long-lived assets, net (property and equipment and intangible assets):</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260630_z27247W8XgI1" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20251231_zMxTJjulRVw1" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_zL4DnIguTxi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">33,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">34,305</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_hsrt--StatementGeographicalAxis__srt--EuropeMember_zMADUHVEPcL4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,089,996</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,228,628</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zEzzJiPp9DN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Totals</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,123,157</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,262,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zb4mDSlKAup9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Long-lived assets, net (property and equipment and intangible assets)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,123,157</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,262,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

SCHEDULE OF SEGMENT REPORTING <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Net sales:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_497_20260101__20260630_zgJVBWPUrXK2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20250101__20250630_zMzlMLOiIiL5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">Net sales:</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_z9fO4Xzp2O7c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">436</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,353</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--StatementGeographicalAxis__srt--EuropeMember_zwGfnxsDb1P5" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">33</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--Revenues_zxWv9uRSzo3l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Totals</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">469</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,353</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--Revenues_z8QbGfAOXATj" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: justify; padding-bottom: 2.5pt">Net sales</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">469</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,353</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">Long-lived assets, net (property and equipment and intangible assets):</td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_49F_20260630_z27247W8XgI1" style="border-bottom: Black 1pt solid; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_491_20251231_zMxTJjulRVw1" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2025</td><td style="padding-bottom: 1pt"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_hsrt--StatementGeographicalAxis__srt--NorthAmericaMember_zL4DnIguTxi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">North America</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">33,161</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">34,305</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_hsrt--StatementGeographicalAxis__srt--EuropeMember_zMADUHVEPcL4" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Europe</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,089,996</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">1,228,628</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zEzzJiPp9DN3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Totals</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,123,157</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,262,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zb4mDSlKAup9" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Long-lived assets, net (property and equipment and intangible assets)</td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,123,157</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">1,262,933</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

436

1353

469

1353

469

1353

33161

34305

1089996

1228628

1123157

1262933

1123157

1262933

Recent Accounting Pronouncements The Company has reviewed all recently issued. In November 2024, the FASB issued ASU No. 2024-03, Disaggregation of Income Statement Expenses (“ASU 2024 03”), and in January 2025, the FASB issued ASU No. 2025-01, Clarifying the Effective Date (“ASU 2025-01”). The amendments are intended to enhance disclosures regarding an entity’s costs and expenses by requiring additional disaggregated information disclosures about certain income statement expense line items. The amendments, as clarified by ASU 2025-01, are effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. The Company is evaluating the effect of adopting the new disclosure requirements. In September 2025, the FASB issued ASU No. 2025-06, Targeted Improvements to the Accounting for Internal-Use Software (“ASU 2025-06”). The amendments are intended to clarify and modernize the accounting for costs related to internal-use software. The guidance removes all references to project stages and clarifies the threshold entities apply to begin capitalizing costs. The amendments are effective for fiscal years beginning after December 15, 2027, and interim periods within those fiscal years, with early adoption permitted. The Company does not expect the adoption to have a material impact on the Company’s financial statements.

NOTE 3 – OTHER RECEIVABLES Other receivables consisted of the following: SCHEDULE OF OTHER RECEIVABLES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_496_20260630_zmMHdah69xra" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20251231_zqoHJw4Z2fr5" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--ValueAddedTaxReceivableCurrent_iI_maORNCzdfb_zYfvreowh9w5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">UK VAT receivable</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">520</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">2,039</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherReceivablesNetCurrent_iTI_mtORNCzdfb_zpWGkcQSBohf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total other receivables</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">520</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,039</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Other receivables consisted of the following: SCHEDULE OF OTHER RECEIVABLES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_496_20260630_zmMHdah69xra" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20251231_zqoHJw4Z2fr5" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40F_eus-gaap--ValueAddedTaxReceivableCurrent_iI_maORNCzdfb_zYfvreowh9w5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 1pt">UK VAT receivable</td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">520</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 16%; text-align: right">2,039</td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OtherReceivablesNetCurrent_iTI_mtORNCzdfb_zpWGkcQSBohf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total other receivables</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">520</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">2,039</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

520

2039

520

2039

NOTE 4 - INTANGIBLE ASSETS Intangible assets consisted of the following: SCHEDULE OF INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_498_20260630_zEf9lOCzkG13" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20251231_z1w6xgk6ssif" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zevwLlyMnlnk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Intellectual properties</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,684,694</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,743,322</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zMRKJqBKhze2" style="vertical-align: bottom; background-color: White"> <td>Patents</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">280,715</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">278,730</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedAcquisitionCostsMember_zqgDHUoTAQml" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Capitalized acquisition costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,745</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,745</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzcuu_z0W2GdbvPnHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total intellectual properties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,011,154</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,067,797</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzcuu_z1bfeNod5xWb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,887,997</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,804,864</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzcuu_z4jZV9fVdht5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intellectual properties, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,123,157</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,262,933</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Patents</td></tr> </table> A Patent on the Internet-Search Mechanism (“IBSM”) has been granted in the United States, South Africa, New Zealand, Canada, and Australia. The patent is pending in the European Union and the United Kingdom. Patents on Contextual Enveloping of Dynamic Hypertext Links and Sensitive Data Protection are pending in the United States. Patents are reported at cost, less accumulated amortization, and accumulated impairment loss. Costs include expenditures directly attributable to the acquisition of the asset. Once a patent has been granted and provides economic benefit to the Company, amortization is provided on a straight-line basis over the expected useful lives of <span id="xdx_904_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zTsOsPpux4X8" title="Intangible assets useful lives">20 years for all patents. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Intellectual Property</td></tr> </table> Intellectual Property capitalizes the Company’s qualifying internal research and development costs. It is amortized over its useful life of <span id="xdx_90A_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_iI_dtY_c20260630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zs5ZmRz4BoM4" title="Intangible assets useful lives">7 years and reported at cost less accumulated amortization and accumulated impairment loss. Amortization expenses were $64,167 and $55,394 for the three months ended June 30, 2026, and 2025, respectively, and $128,628 and $109,348 for the six months ended June 30, 2026, and 2025, respectively.

Intangible assets consisted of the following: SCHEDULE OF INTANGIBLE ASSETS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_498_20260630_zEf9lOCzkG13" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49D_20251231_z1w6xgk6ssif" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zevwLlyMnlnk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Intellectual properties</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,684,694</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">3,743,322</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zMRKJqBKhze2" style="vertical-align: bottom; background-color: White"> <td>Patents</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">280,715</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">278,730</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--CapitalizedAcquisitionCostsMember_zqgDHUoTAQml" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Capitalized acquisition costs</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,745</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">45,745</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_maIANEGzcuu_z0W2GdbvPnHi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total intellectual properties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,011,154</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">4,067,797</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iNI_di_msIANEGzcuu_z1bfeNod5xWb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: accumulated amortization</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,887,997</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(2,804,864</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iTI_mtIANEGzcuu_z4jZV9fVdht5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total intellectual properties, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,123,157</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,262,933</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

3684694

3743322

280715

278730

45745

4011154

4067797

2887997

2804864

1123157

1262933

P20Y

P7Y

64167

55394

128628

109348

NOTE 5 – ACCOUNTS PAYABLE Accounts payable consist entirely of short-term, non-interest-bearing obligations due to trade vendors and suppliers for goods and services. Standard payment terms range from 30 to 60 days. As of June 30, 2026, and December 31, 2025, accounts payable were $398,995 and $368,444, respectively.

398995

368444

NOTE 6 – ACCRUED LIABILITIES Accrued liabilities consisted of the following: SCHEDULE OF ACCRUED LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20260630_zvpmJUWfyPp9" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_499_20251231_zxHeEtGVENke" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--InterestPayableCurrent_iI_maALCzVB1_zG2tAhGs443i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Interest payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">89,157</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">32,022</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzVB1_zmO3RcKIYw0i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other accruals</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,386</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,990</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maALCzVB1_zl2H3ssvqZ21" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Salaries payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">212,176</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191,303</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SettlementLiabilitiesCurrent_iI_maALCzVB1_z0eTtvD80RB4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Settlements payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">934,795</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">936,187</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_mtALCzVB1_z0J2hw24yzB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Accrued Liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,308,514</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,233,502</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

Accrued liabilities consisted of the following: SCHEDULE OF ACCRUED LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20260630_zvpmJUWfyPp9" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_499_20251231_zxHeEtGVENke" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_400_eus-gaap--InterestPayableCurrent_iI_maALCzVB1_zG2tAhGs443i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Interest payable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">89,157</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">32,022</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_maALCzVB1_zmO3RcKIYw0i" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other accruals</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,386</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">73,990</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_maALCzVB1_zl2H3ssvqZ21" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Salaries payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">212,176</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">191,303</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--SettlementLiabilitiesCurrent_iI_maALCzVB1_z0eTtvD80RB4" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Settlements payable</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">934,795</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">936,187</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--AccruedLiabilitiesCurrentAndNoncurrent_iTI_mtALCzVB1_z0J2hw24yzB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total Accrued Liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,308,514</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,233,502</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

89157

32022

72386

73990

212176

191303

934795

936187

1308514

1233502

NOTE 7 – DUE TO RELATED PARTIES (CURRENT) The Company had the following amounts due to related parties classified within current liabilities as of June 30, 2026, and December 31, 2025: SCHEDULE OF RELATED PARTIES CLASSIFIED WITHIN CURRENT LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20260630_zkXWV3EjMgj5" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_499_20251231_zYJud9jFU6q6" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_maOLCzSqz_z0Iclv0FULge" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Accrued Salaries and Benefits – Directors and Officers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">908,069</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">786,757</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ReimbursableExpenses_iI_maOLCzSqz_zh7yoyWTSIak" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Reimbursable Expenses – Directors and Officers</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">44,834</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">49,625</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ShortTermBorrowings_iI_maOLCzSqz_zA4PzqaYp56d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Related Party Short-Term Loans – Shareholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">54,696</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzSqz_zxThj2MRsVVd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total Due to Related Parties</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,007,599</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">836,382</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> As of June 30, 2026, accrued salaries and benefits for directors and officers totalled $908,069. Due to ongoing working capital constraints, the Company’s executive officers have contractually deferred receipt of cash for their compensation, and no cash payments for executive payroll have been made since fiscal year 2022. These outstanding balances remain unsecured, non-interest-bearing, and payable on demand. Management intends to satisfy these accrued historical obligations solely from future operational revenues; any proceeds obtained from operational or equity funding tracks will be utilized exclusively to support future operations, including ongoing current payroll requirements. The remaining balances due to related parties represent short-term obligations for operational expense reimbursements and working capital cash advances provided by certain shareholders. These current liabilities are unsecured, non-interest-bearing, and payable on demand.

The Company had the following amounts due to related parties classified within current liabilities as of June 30, 2026, and December 31, 2025: SCHEDULE OF RELATED PARTIES CLASSIFIED WITHIN CURRENT LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_49B_20260630_zkXWV3EjMgj5" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" id="xdx_499_20251231_zYJud9jFU6q6" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="text-align: center; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--AccruedSalariesCurrent_iI_maOLCzSqz_z0Iclv0FULge" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: justify">Accrued Salaries and Benefits – Directors and Officers</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">908,069</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">786,757</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_ecustom--ReimbursableExpenses_iI_maOLCzSqz_zh7yoyWTSIak" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify">Reimbursable Expenses – Directors and Officers</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">44,834</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">49,625</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ShortTermBorrowings_iI_maOLCzSqz_zA4PzqaYp56d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 1pt">Related Party Short-Term Loans – Shareholders</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">54,696</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzSqz_zxThj2MRsVVd" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Total Due to Related Parties</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,007,599</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">836,382</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

908069

786757

44834 49625

54696

1007599

836382

908069

NOTE 8 – CONVERTIBLE NOTES (HOST DEBT INSTRUMENT) As of June 30, 2026, the Company’s outstanding convertible debt host instruments classified within current liabilities had an aggregate carrying value of $241,656, consisting of $66,241 in convertible notes net of an associated unamortized debt discount of $175,415. These components represent the unamortized allocation blocks of the underlying short-term debt host instruments as of the balance sheet date. Pursuant to ASC 835-30, these host tranches are stated net of their respective unamortized debt discounts, which were initially generated by the detachment and fair value bifurcation of their embedded derivative liabilities at the inception of the respective offerings. These discounts are being systematically amortized to interest expense over the remaining contractual maturities of the underlying credit facilities.

241656

66241

175415

NOTE 9 - DERIVATIVE LIABILITY On April 4, 2025, the Company approved the issuance of up to $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20250404__20250404__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_z6ByIbXB7vRg" title="Issuance of convertible loan notes">500,000 in convertible loan notes. The notes accrue interest at an annual rate of <span id="xdx_904_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_uPure_c20250404__20250404__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zRZIZCnrhkR9" title="Accrued interest annual rate">18%. The maturity date is twelve months from the date of issuance. On July 15, 2025, the Company approved the issuance of up to $<span id="xdx_900_eus-gaap--ProceedsFromConvertibleDebt_c20250715__20250715__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zh1TEZkOOCJ" title="Issuance of convertible loan notes">775,000 in convertible loan notes. The notes accrue interest at an annual rate of <span id="xdx_903_eus-gaap--DebtInstrumentInterestRateDuringPeriod_pid_dp_c20250715__20250715__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zLlHc9FrghK2" title="Accrued interest annual rate">12%. The maturity date is six months from the date of issuance. <p id="xdx_893_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zhI5tFmUQRTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents the roll-forward of the Company’s derivative liability measured at fair value using Level 3 inputs for the six months ended June 30, 2026, and the year ended December 31, 2025: SCHEDULE OF DERIVATIVE LIABILITIES MEASURED AT FAIR VALUE LEVEL 3 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zc5xI6Nyf2F3" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgig0qikAyCf" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--ConvertibleDebt_iS_zekFuVsS7lYa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Opening Balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">479,865</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--FaceValueOfNewIssuances_zhHQCxgNj2Sl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Face value of new issuances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">103,872</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">445,219</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--LossOnDerivativeIssuance_zXv3O6erRzdf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on derivative issuance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,177</td><td style="text-align: left"></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">879,757</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--PaymentsDerivativeLiability_iN_di_zrmzLKn20dnk" style="vertical-align: bottom; background-color: White"> <td>Payments derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(20,509</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--Conversions_zUdBIu9gzJli" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Conversions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(60,179</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DerivativeGainLossOnDerivativeNet_zALPYMrnhFhb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Change in fair value of derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(363,124</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(845,111</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ConvertibleDebt_iE_zsJq4j8dfqU9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Ending Balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">212,102</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">479,865</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Company’s derivative financial instruments are classified as derivative liabilities and are measured at fair value on a recurring basis. On January 1, 2025, and January 1, 2026, the derivative liability balance was $0 and $479,865, respectively. During the six months ended June 30, 2026, the derivative liability balance changed due to the face value of new issuances of $103,872 and an associated loss on derivative issuance of $72,177. These increases were offset by payments of derivative liability value of $20,509, and conversions of $60,179. Additionally, the Company recognized a non-cash gain of $363,124 from changes in the fair value of derivative liabilities, which is recorded within other income (expense) in the consolidated statement of operations. As of June 30, 2026, the total outstanding derivative liability balance was $212,102. In accordance with SEC Staff Accounting Bulletin No. 108, management evaluated these items and concluded that the underlying errors were immaterial to all prior periods, both individually and in the aggregate. Accordingly, the adjustments were recognized entirely within the current quarter’s Consolidated Statement of Operations. During the preparation of the condensed consolidated financial statements for the quarter ended June 30, 2026, management identified an accounting omission regarding the historical non-cash interest expense associated with the accretion of debt discounts on certain notes payable issued during fiscal year 2025. Specifically, the Company had omitted periodic straight-line accretion of debt discounts from inception through March 31, 2026, on its $57,000 note payable issued on October 9, 2025, and its $<span id="xdx_90F_eus-gaap--ProceedsFromConvertibleDebt_c20250404__20250404__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_ziBYlIrCew3e" title="Issuance of convertible loan notes">500,000 note payable offering initiated on April 4, 2025. Both instruments were initially assigned a $0 carrying value because the fair value of their bifurcated embedded derivative liabilities exceeded total cash proceeds, creating a debt discount to be amortized over the respective contractual terms of the agreements pursuant to ASC 835-30-35-2. In accordance with SEC Staff Accounting Bulletin (“SAB”) No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, and SAB No. 99, Materiality, the Company evaluated the quantitative and qualitative materiality of these errors on all affected prior interim and annual financial periods. Management determined that the cumulative under-recording of non-cash interest expense of $106,729 (consisting of $41,162 related to the fiscal year ended December 31, 2025, and $65,567 related to the three months ended March 31, 2026) was quantitatively and qualitatively immaterial to all prior historical periods, as well as to full-year operational expectations for fiscal year 2026. Accordingly, the Company recorded a cumulative out-of-period catch-up correction of $106,729 within interest expense in the Condensed Consolidated Statement of Operations for the three months and six months ended June 30, 2026. This adjustment was recorded alongside standalone current-quarter accretion of $67,686, resulting in a total non-cash note accretion interest charge of $174,415 for the three months ended June 30, 2026. The recording of this cumulative correction had no impact on the Company’s historically reported revenues, operational cash flows, or structural liquidity metrics.

500000

0.18

775000

0.12

<p id="xdx_893_eus-gaap--ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_zhI5tFmUQRTe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The following table presents the roll-forward of the Company’s derivative liability measured at fair value using Level 3 inputs for the six months ended June 30, 2026, and the year ended December 31, 2025: SCHEDULE OF DERIVATIVE LIABILITIES MEASURED AT FAIR VALUE LEVEL 3 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49F_20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zc5xI6Nyf2F3" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20250101__20251231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgig0qikAyCf" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_403_eus-gaap--ConvertibleDebt_iS_zekFuVsS7lYa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Opening Balance</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">479,865</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--FaceValueOfNewIssuances_zhHQCxgNj2Sl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Face value of new issuances</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">103,872</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">445,219</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--LossOnDerivativeIssuance_zXv3O6erRzdf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss on derivative issuance</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">72,177</td><td style="text-align: left"></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">879,757</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_ecustom--PaymentsDerivativeLiability_iN_di_zrmzLKn20dnk" style="vertical-align: bottom; background-color: White"> <td>Payments derivative liability</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(20,509</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--Conversions_zUdBIu9gzJli" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Conversions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(60,179</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DerivativeGainLossOnDerivativeNet_zALPYMrnhFhb" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Change in fair value of derivative liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(363,124</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(845,111</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--ConvertibleDebt_iE_zsJq4j8dfqU9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Ending Balance</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">212,102</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">479,865</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

479865

103872 445219 72177 879757 20509 -60179

-363124

-845111

212102

479865

103872 72177 -20509 -60179 363124

212102

57000

500000

106729

41162

65567

106729

67686 174415

NOTE 10 – MATURED LOAN NOTES PAYABLE As of June 30, 2026 and December 31, 2025, the Company had outstanding matured loan notes payable within current liabilities of $197,365 and $0, respectively. These outstanding balances consist of short-term convertible loan notes previously recorded as derivative liabilities that reached their contractual maturity dates during the six months ended June 30, 2026, without undergoing cash repayment or conversion into common stock. Upon maturity, the embedded conversion features expired, and the associated bifurcated embedded derivative liabilities were derecognized. In a non-cash financing transaction, the aggregate carrying value of $197,365 was systematically reclassified from derivative liabilities to standard matured loan notes payable within current liabilities. These past-due obligations remain unsecured, non-interest-bearing, and payable on demand.

197365

NOTE 11 – LOANS PAYABLE TO RELATED PARTIES <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVcVF4vDdLl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Company had the following loans payable to related parties: SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20260101__20260630_zBKBNZPItow1" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20250101__20251231_z44LDM03pzhk" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--LoansPayableCurrent_iS_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zDpvuwn1Nvfb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance: Loans 1 - payable to Stephen Morris</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">668,405</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">561,833</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--AdditionToLoansPayableCurrent_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zYFlW3ds08A9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">97,291</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--PaydownToLoansPayableCurrent_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zOfeU1HyQW4a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Paydown</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,541</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ForeignCurrencyTranslationAdjustmentsToLoansPayableCurrent_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zx1SrcnvkxMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">Foreign currency translation adjustments</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,590</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">9,281</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--NetChangeInLoan1_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zJAlbxCe3BOa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Net change in Loan 1</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(15,131</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">106,572</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LoansPayableCurrent_iE_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zwaHzXqx0dGd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ending balance Loan 1 – payable to Stephen Morris</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">653,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">668,405</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan 2 - payable to Stephen Morris</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--LoansPayable_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember_zgU70rHZ6Eef" style="text-align: right" title="Loan 2 payable">575,646</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--LoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember_zpoEnUWw2Lbd" style="text-align: right" title="Loan 2 payable">584,805</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total loan payable to related parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--LoansPayable_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zq9mHdyxVKve" style="text-align: right" title="Total loan payable to related parties">1,228,920</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--LoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zt7bEGGduP3d" style="text-align: right" title="Total loan payable to related parties">1,253,210</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--LoansPayableCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z117zJj33hra" style="border-bottom: Black 1pt solid; text-align: right" title="Total current portion">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--LoansPayableCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQMCE3vn0Luh" style="border-bottom: Black 1pt solid; text-align: right" title="Total current portion">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total – non-current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--LongTermLoansPayable_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyyjbpp9Jmsh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total noncurrent">1,228,920</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermLoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zA0rdeoWVHgi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total noncurrent">1,253,210</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Loan 1 (January 16, 2016) - Stephen Morris, Founder, CTO, and Chair.</td></tr> </table> On January 16, 2016, our wholly owned subsidiary, Bubblr Limited, entered into a Loan Agreement (the “Loan Agreement”) with Mr. Stephen Morris. The Loan Agreement is unsecured and bears no interest. It was payable on demand and is intended for working capital or as the Company deems appropriate. The Loan is available for drawing by the Company in multiple tranches. On September 30, 2024, the parties desired to amend the loan such that the principal amount of the loan shall be due and payable by Borrower to Lender on the earlier of (i) the completion of an equity offering by Bubblr, Inc., for no less than $<span id="xdx_906_eus-gaap--ProceedsFromOtherEquity_c20240930__20240930__us-gaap--TypeOfArrangementAxis__custom--SixthAmendmentMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember_zGfqsIncyJff">5,000,000, or (ii) three years from the date of this Amendment. Loan 1 is denominated in British Pounds (GBP) and translated into U.S. Dollars (USD) at each reporting date. Accordingly, the periodic fluctuations in the carrying values of both instruments were driven by non-cash foreign currency translation adjustments moving through the statement of comprehensive income. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Loan 2 (September 7, 2022) - Stephen Morris, Founder, CTO, and Chair.</td></tr> </table> On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for $<span id="xdx_906_eus-gaap--DebtInstrumentFaceAmount_iI_c20220907__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember_zm2ZvdIPbUAb" title="Debt instrument face amount">501,049 (£<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_uEuro_c20220907__us-gaap--TypeOfArrangementAxis__custom--LoanAgreementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember_z31rS7Rta529" title="Debt instrument face amount">434,060). The Loan Agreement is unsecured, carries no interest, is non-convertible, and is due upon maturity. The Loan is available for drawing by the Company in multiple tranches. On September 30, 2024, the parties agreed to amend the loan, with the maturity date set three years from the date of this amendment. Loan 2 is denominated in British Pounds (GBP) and translated into U.S. Dollars (USD) at each reporting date. Accordingly, the periodic fluctuations in the carrying values of both instruments were driven entirely by non-cash foreign currency translation adjustments moving through the statement of comprehensive income.

<p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zVcVF4vDdLl9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The Company had the following loans payable to related parties: SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20260101__20260630_zBKBNZPItow1" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_49E_20250101__20251231_z44LDM03pzhk" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr id="xdx_40B_eus-gaap--LoansPayableCurrent_iS_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zDpvuwn1Nvfb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Beginning balance: Loans 1 - payable to Stephen Morris</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">668,405</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">561,833</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_ecustom--AdditionToLoansPayableCurrent_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zYFlW3ds08A9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Additions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">97,291</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_ecustom--PaydownToLoansPayableCurrent_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zOfeU1HyQW4a" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Paydown</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,541</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--ForeignCurrencyTranslationAdjustmentsToLoansPayableCurrent_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zx1SrcnvkxMl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt; text-align: left">Foreign currency translation adjustments</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,590</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">9,281</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--NetChangeInLoan1_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zJAlbxCe3BOa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Net change in Loan 1</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(15,131</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">106,572</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LoansPayableCurrent_iE_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember__us-gaap--DebtInstrumentAxis__custom--LoanOneMember_zwaHzXqx0dGd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Ending balance Loan 1 – payable to Stephen Morris</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">653,274</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">668,405</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan 2 - payable to Stephen Morris</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--LoansPayable_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember_zgU70rHZ6Eef" style="text-align: right" title="Loan 2 payable">575,646</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--LoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--StephenMorrisMember_zpoEnUWw2Lbd" style="text-align: right" title="Loan 2 payable">584,805</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total loan payable to related parties</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--LoansPayable_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zq9mHdyxVKve" style="text-align: right" title="Total loan payable to related parties">1,228,920</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--LoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zt7bEGGduP3d" style="text-align: right" title="Total loan payable to related parties">1,253,210</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Less current portion</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--LoansPayableCurrent_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_z117zJj33hra" style="border-bottom: Black 1pt solid; text-align: right" title="Total current portion">—</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--LoansPayableCurrent_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zQMCE3vn0Luh" style="border-bottom: Black 1pt solid; text-align: right" title="Total current portion">—</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total – non-current</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--LongTermLoansPayable_iI_c20260630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zyyjbpp9Jmsh" style="border-bottom: Black 2.5pt double; text-align: right" title="Total noncurrent">1,228,920</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--LongTermLoansPayable_iI_c20251231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zA0rdeoWVHgi" style="border-bottom: Black 2.5pt double; text-align: right" title="Total noncurrent">1,253,210</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

668405

561833

97291 -4541 -10590 9281 -15131 106572

653274

668405

575646

584805

1228920

1253210

1228920

1253210

5000000

501049

434060

NOTE 12 – WARRANT LIABILITY The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock (see Note 6) for derivative accounting consideration under ASC 815, “Derivatives and Hedging,” and determined that the instruments should be classified as liabilities due to reset provisions and exercise price variability. These features result in there being no fixed value or explicit limit to the number of shares to be delivered upon exercise. ASC 815 requires the Company to assess the fair value of derivative liabilities at the end of each reporting period and recognize any change in fair value within current period earnings as other income or expense. The Company determined its warrant liabilities to be Level 3 fair value measurements based on the use of significant unobservable inputs. Management used the Black-Scholes pricing model to calculate the fair value at each reporting date. The Black-Scholes model requires six basic inputs: the exercise price, time to expiration, risk-free interest rate, current stock price, estimated future stock price volatility, and expected dividend yield. Changes to these inputs could produce a significantly higher or lower fair value measurement. <p id="xdx_89B_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zfXlb9YNx9A6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zcq5TCXrGM9" title="Expected term">0.34 – <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260630__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_znMrkSqVIR4j" title="Expected term">0.49</td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Expected average volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_z8Q8DVExgcFc" title="Warrants and rights outstanding, measurement input">210% - <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zNkekug1Cogg" title="Warrants and rights outstanding, measurement input">232</td><td style="text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Expected dividend yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z97RlOAtcbGg" title="Warrants and rights outstanding, measurement input">8.33</td><td style="width: 1%; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zZGW820EBPb1" title="Warrants and rights outstanding, measurement input">3.38% - <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z44LpjRitXa7" title="Warrants and rights outstanding, measurement input">5.04</td><td style="text-align: left">%</td> </tr> </table> <p id="xdx_89A_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zfz8Ue6U9jGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes the changes in the warrant liabilities during the six months ended June 30, 2026: SUMMARY OF CHANGES IN WARRANT LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td colspan="4" style="border-bottom: Black 1pt solid; text-align: center">Fair Value Measurements Using Significant Unobservable Inputs (Level 3)</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Warrant liability December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement_iS_c20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgfqhntt4zec" style="width: 16%; text-align: right" title="Warrant liability, beginning balance">231</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Addition of new warrants</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--AdditionOfNewWarrants_c20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGccmspn2qR9" style="text-align: right" title="Addition of new warrants">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Change in fair value of warrant liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_c20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfqcEkkN4p24" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value of warrant liability">(231</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Warrant liability as of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement_iE_c20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrTtpPdR4Z73" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant liability, beginning balance">0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

<p id="xdx_89B_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zfXlb9YNx9A6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Six Months Ended</td><td style="font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected term (years)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember__srt--RangeAxis__srt--MinimumMember_zcq5TCXrGM9" title="Expected term">0.34 – <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20260630__srt--RangeAxis__srt--MaximumMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_znMrkSqVIR4j" title="Expected term">0.49</td><td style="text-align: left"> </td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td>Expected average volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_z8Q8DVExgcFc" title="Warrants and rights outstanding, measurement input">210% - <span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zNkekug1Cogg" title="Warrants and rights outstanding, measurement input">232</td><td style="text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Expected dividend yield</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_909_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z97RlOAtcbGg" title="Warrants and rights outstanding, measurement input">8.33</td><td style="width: 1%; text-align: left">%</td> </tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zZGW820EBPb1" title="Warrants and rights outstanding, measurement input">3.38% - <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20260630__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_z44LpjRitXa7" title="Warrants and rights outstanding, measurement input">5.04</td><td style="text-align: left">%</td> </tr> </table>

P0Y4M2D

P0Y5M26D

210

232

8.33

3.38

5.04

<p id="xdx_89A_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zfz8Ue6U9jGj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">The following table summarizes the changes in the warrant liabilities during the six months ended June 30, 2026: SUMMARY OF CHANGES IN WARRANT LIABILITIES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td colspan="4" style="border-bottom: Black 1pt solid; text-align: center">Fair Value Measurements Using Significant Unobservable Inputs (Level 3)</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Warrant liability December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement_iS_c20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgfqhntt4zec" style="width: 16%; text-align: right" title="Warrant liability, beginning balance">231</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Addition of new warrants</td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_ecustom--AdditionOfNewWarrants_c20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zGccmspn2qR9" style="text-align: right" title="Addition of new warrants">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt">Change in fair value of warrant liability</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss_c20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zfqcEkkN4p24" style="border-bottom: Black 1pt solid; text-align: right" title="Change in fair value of warrant liability">(231</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Warrant liability as of June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedNotSubjectToMasterNettingArrangement_iE_c20260101__20260630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zrTtpPdR4Z73" style="border-bottom: Black 2.5pt double; text-align: right" title="Warrant liability, beginning balance">0</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

231

-231

NOTE 13 - STOCKHOLDERS’ EQUITY Preferred Stock The Company has authorized 25,000,000 preferred shares with a par value of $0.001 per share. The Board of Directors is authorized to divide the authorized shares of Preferred Stock into one or more series, each of which should be so designated as to distinguish the shares thereof from the shares of all other series and classes. Series C Convertible Preferred Stock On March 4, 2023, the Company filed a Certificate of Designation with the Wyoming Secretary of State, establishing 2,000 shares of the Company’s Series C Convertible Preferred Stock with a Stated Value of $1,200 per share. The Company reserves the right to redeem Series C Convertible Preferred Stock in accordance with the following schedule. <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">If all of the Series C Convertible Preferred Stock are redeemed within 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 115% of the Stated Value together with any accrued but unpaid dividends.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">If all of the Series C Convertible Preferred Stock is redeemed after 90 calendar days from the issuance date thereof, the Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">The Company shall pay an 8% per annum dividend on the Series C Convertible Preferred Stock. Dividends shall be paid quarterly, and at the Company’s discretion, in cash or Series C Convertible Preferred Stock. The dividend shall be deemed to accrue from the date of issuance of the Series C Convertible Preferred Stock, whether earned or declared, and whether there are profits, surplus, or other funds of the Company legally available for the payment of dividends. However, during 2025, the Company determined that it was insolvent and, accordingly, ceased accruing dividends on the Series C Convertible Preferred Stock and reversed previously accrued dividends. This determination was based on the applicable requirements under Wyoming law, which restrict a corporation from making a distribution if, after giving effect to such distribution, the corporation would be unable to pay its debts as they become due in the usual course of business or would otherwise fail the applicable balance-sheet test. Accordingly, as the Company was insolvent and the applicable financial-condition requirements for a lawful dividend distribution were not satisfied, the Company did not accrue or declare dividends on the Series C Convertible Preferred Stock during the applicable period.</td></tr> </table> The Series C Convertible Preferred Stock shall have voting rights alongside the common stock on an as-converted basis, subject to the Beneficial Ownership Limitations as outlined in the Certificate of Designation. Each share of the Series C Convertible Preferred Stock can be converted at any time after issuance, at the Holder’s option, into shares of Common Stock (subject to Beneficial Ownership Limitations), determined by dividing the Stated Value of $<span id="xdx_907_eus-gaap--PreferredStockLiquidationPreferenceValue_iI_c20230304__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zPkJnwy9GlM9" title="Preferred stock, liquidation preference value">1,200 per share by the Conversion Price of $0.3202. During the year ended December 31, 2025, the Company converted 120 shares of Series C Preferred Stock with a stated value of $<span id="xdx_90A_eus-gaap--ConversionOfStockAmountConverted1_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zUl7R0wE8Xxe" title="Number of shares converted, value">144,000. As of June 30, 2026, and December 31, 2025, the Company had <span id="xdx_90A_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20260630__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zIBPFQwD3GO4" title="Preferred stock, shares outstanding"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_pid_c20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zV5HaPYCiYFk" title="Preferred stock, shares outstanding">783 shares of Series C Preferred Stock issued and outstanding. Common Stock The Company has authorized 3,000,000,000 ordinary shares with a par value of $0.01 per share. Each common share entitles the holder to one vote, in person or by proxy, on any matter on which action of the corporation’s stockholders is sought. During the years ended December 31, 2025, and the six months ended June 30, 2026, the Company issued common shares as follows: Year ended December 31, 2025 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementClassOfStockAxis__custom--SeriesCConvertiblePreferredStockMember_z1zpT7wn5aI2" title="Number of conversion shares">17,698,338 shares for the conversion of Series C Convertible Preferred Stock with a stated value of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20250101__20251231__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesCPreferredStockMember_zK0qp0pAR2Vk" title="Number of conversion shares, value">144,000.</td></tr> </table> Three months ended March, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 0.5in; font-size: 12pt"> </td> <td style="width: 0.25in; font-size: 12pt">●</td> <td style="font-size: 12pt; text-align: justify"><span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260401__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertibleCommonStockMember_zGnWzTHZvhig" title="Number of conversion shares">14,270,720 shares for the conversion of Convertible Promissory Notes with a value of $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20260401__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertibleCommonStockMember_z3V6hDOskuQk" title="Number of conversion shares, value">30,000.</td></tr> </table> Six months ended June 30, 2026 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertibleCommonStockMember_zumkcrWIRvqh" title="Number of conversion shares">72,742,222 shares for the conversion of Convertible Promissory Notes with a value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c20260101__20260630__us-gaap--StatementClassOfStockAxis__us-gaap--ConvertibleCommonStockMember_zQS04elsUGn8" title="Number of conversion shares, value">130,640.</td></tr> </table> The Company had 250,331,008 and 177,588,785 shares of common stock issued and outstanding as of June 30, 2026, and December 31, 2025, respectively. Warrants The Company identified conversion features embedded within warrants issued during the year ended December 31, 2022. The Company has determined that the conversion feature of the Warrants constitutes an embedded derivative because the conversion price includes a reset provision, which could result in adjustments to the redemption value and the number of shares issued upon exercise (see Note 8 - Warrant Liability). <p id="xdx_89F_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zpG6drsNgD6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A summary of activity during the six months ended June 30, 2026, follows: SUMMARY OF WARRANTS ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; text-align: center">Weighted Average</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">Number of</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> Remaining life</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(years)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260630_zPFZZmxMvBGe" style="width: 12%; text-align: right" title="Number of warrants outstanding beginning balance">2,538,101</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260630_ze6bNzggElX3" style="width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance">0.3160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231_zWsAnc8UVrfj" title="Weighted average remaining life (years)">1.24</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630_zPwaOx7JXxx7" style="text-align: right" title="Number of warrants, granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630_zcapSex1KdY7" style="text-align: right" title="Weighted average exercise price, outstanding granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630_zzZzU5M1pezd" style="text-align: right" title="Number of warrants, exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630_zX1XgX5doaD6" style="text-align: right" title="Weighted average exercise price, outstanding exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Forfeited/canceled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20260101__20260630_zeoS4sQlTzq7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, forfeited/canceled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630_zqe1LtpM53Ll" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, outstanding forfeited/canceled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260630_zFgbrwel8bfh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding ending balance">2,538,101</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260630_zVBDACohOJs7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance">0.3160</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260630_zCYyTxhzblre" title="Weighted average remaining life (years)">0.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable Warrants, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20260101__20260630_zc5me2aNBeHi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, exercisable">2,538,101</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260630_zTk5WsDdlw11" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">0.3160</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630_zgxEHbWK5Pw3" title="Weighted average remaining life (years) exercisable warrants">0.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_89C_ecustom--SummaryOfInformationRelatingToOutstandingAndExercisableWarrantsTableTextBlock_zVigFYpO7kz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following table summarizes information relating to outstanding and exercisable warrants as of June 30, 2026: SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number of Warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Weighted Average Remaining Contractual life (in years)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Weighted Average Exercise Price</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOneMember_zB0NP4BRj6Hh" style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: right" title="Number of warrants, outstanding">941,599</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOneMember_z7IdOB4KQYc2" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.25</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOneMember_z8A3EfvgAaLd" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.3404</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsTwoMember_zjZwNZA3PqUh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">472,205</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsTwoMember_ziphh5Tt1hHk" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.12</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsTwoMember_zWyhSpEcbXEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.3404</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsThreeMember_zhPM2TdNUmAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">562,149</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsThreeMember_zlUheCifFY49" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.17</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsThreeMember_zFYRJUBCiJne" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.3503</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFourMember_zH28zXF5ldwf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">281,074</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFourMember_zf7uotwZuE9l" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.09</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFourMember_znNec0QvI9q6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.2170</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFiveMember_zRhFoYex4wC4" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">281,074</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFiveMember_zRSHj0sJMbqe" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.10</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFiveMember_zRZfX05T9lu" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.2236</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630_zXZKJAxmuV5d" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">2,538,101</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630_zxmpuR98gQh" title="Weighted average remaining life contractual life (years), warrants outstanding">0.73</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630_zHq56E6EiTff" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, warrants outstanding">0.3160</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table> As of June 30, 2026, the intrinsic value of the warrants is $<span id="xdx_905_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_c20260630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zvOqLXNA2rQk" title="Intrinsic value">0, as the price of the Company’s stock was below the warrant exercise price. Equity Incentive Plan On May 25, 2022, our board of directors and majority shareholders approved the adoption of the Bubblr, Inc. 2022 Equity Incentive Plan (the “2022 Plan”), which will remain in effect, unless earlier terminated, until May 25, 2032. Up to 28,400,000 shares of common stock may be issued under the 2022 Plan. The 2022 Plan aims to enhance our ongoing financial stability and increase shareholder value by motivating performance through incentive compensation. It is designed to encourage participants to acquire and maintain ownership interests in our organization, while also attracting and retaining talented individuals whose judgment and efforts are essential to our enterprise’s success. On January 14, 2025, an executive forfeited 1,395,000 unvested stock options to purchase shares of our common stock upon termination of service. On April 4, 2025, our Board of Directors authorized the implementation of the Bubblr, Inc. 2025 Employee and Consultant Stock Plan (“2025 Plan”), which shall remain in effect until April 4, 2035, unless terminated sooner. A maximum of <span id="xdx_909_ecustom--StockIssuedDuringPeriodEquityFinanceAgreementShares_c20250404__20250404__us-gaap--PlanNameAxis__custom--TwoThousadTwentyFiveEmployeeAndConsultantStockPlanMember_zG1OARjTIfMi" title="Shares of common stock">30,000,000 shares of common stock may be issued pursuant to the 2025 Plan. The Board of Directors establishes the criteria for allocating stock options, aligning with the stipulations outlined in our 2022 and 2025 Plans. Our general policy for granting stock options is that a portion of the options vests after 90 days of service, with the remainder vesting incrementally over the next two years. The maximum validity period for the options is ten years. On April 15, 2025, the Company granted <span id="xdx_907_ecustom--StockIssuedDuringPeriodEquityFinanceAgreementShares_c20250415__20250415__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__srt--ExecutiveOfficerMember_z9x8eCUiYrBb" title="Shares of common stock">3,360,000 stock options to an executive to purchase shares of our Common Stock. On May 20, 2025, the Company granted <span id="xdx_90E_ecustom--StockIssuedDuringPeriodEquityFinanceAgreementShares_c20250520__20250520__us-gaap--PlanNameAxis__custom--TwoThousadTwentyFiveEmployeeAndConsultantStockPlanMember__srt--TitleOfIndividualAxis__custom--ConsultantsMember_zzwmquCtLozf" title="Shares of common stock">2,750,000 stock options to consultants to purchase shares of our Common Stock. On June 11, 2025, the Company granted <span id="xdx_900_ecustom--StockIssuedDuringPeriodEquityFinanceAgreementShares_c20250611__20250611__us-gaap--PlanNameAxis__custom--EquityIncentivePlanMember__srt--TitleOfIndividualAxis__custom--EmployeeMember_zULVaNXkK1jc" title="Shares of common stock">500,000 stock options to an employee to purchase shares of our Common Stock. On June 11, 2025, an executive forfeited 840,000 unvested options to purchase our common stock upon the termination of their service. On June 13, 2025, the Company granted 1,000,000 stock options to an attorney to purchase the Company’s common stock. On June 19, 2025, the Company granted <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20250619__20250619__srt--TitleOfIndividualAxis__custom--SixConsultantsMember_zpfVIeChl9E5" title="Options granted">1,500,000 stock options to six consultants to purchase the Company’s common stock. On November 5, 2025, the Company granted <span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20251105__20251105__srt--TitleOfIndividualAxis__custom--ExecutiveMember_zazlRkdab5db" title="Options granted">2,250,000 stock options to an executive to purchase shares of our Common Stock. On November 18, 2025, the Company granted <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20251118__20251118__srt--TitleOfIndividualAxis__custom--NonExecutiveMember_zSH45tthuQw8" title="Options granted">200,000 stock options to a non-executive director to purchase shares of our Common Stock. On April 16, 2025, an executive forfeited 4,805,000 unvested options to purchase our common stock due to termination of their service. The weighted-average fair value of stock options granted was determined using the Black-Scholes option-pricing model with the following weighted-average assumptions. See below for reference to the Company’s valuation methodologies for these grants. <p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zW8vTfgdzbge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__srt--RangeAxis__srt--MinimumMember_z16iqRz4vJli" title="Expected life in years">6.76 – <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__srt--RangeAxis__srt--MaximumMember_zLt3Q1pPIOX3" title="Expected life in years">9.39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zRl2wJ1whYve" title="Expected life in years">7.25 – <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_z0yr58qtvFtj" title="Expected life in years">9.88</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20260101__20260630_zAcjQV4LDX3k" title="Risk-free interest rate">4.31</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20250101__20251231_zOHf3N6E0aY6" title="Risk-free interest rate">4.29</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Annual forfeiture rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">192</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">252</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table> No stock options were granted in the six months ended June 30, 2026. <p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDj5antZdHL7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following table summarizes the stock options activity for the six months ended June 30, 2026, and the year ended December 31, 2025: SUMMARY OF STOCK OPTION ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Outstanding at the beginning of the period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20260101__20260630_zXOjjXoewlL2" style="width: 16%; text-align: right" title="Number of shares, outstanding beginning balance">26,705,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20250101__20251231_z2XwWWeopTQf" style="width: 16%; text-align: right" title="Number of shares, outstanding beginning balance">17,380,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20260101__20260630_z9flwwndgbc4" style="text-align: right" title="Number of shares outstanding, granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20250101__20251231_zw6MfFDjZWs5" style="text-align: right" title="Number of shares outstanding, granted">11,560,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_iN_pid_di_c20260101__20260630_zMoCeawjzRe5" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares outstanding, forfeited">(4,805,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_iN_pid_di_c20250101__20251231_zytWOljSU6Hg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares outstanding, forfeited">(2,235,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Outstanding at the end of the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20260101__20260630_zCbbcOVPDXAb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, outstanding ending balance">21,900,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20250101__20251231_zlW2xchigSQi" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, outstanding ending balance">26,705,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average contractual life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260630_zU8b6ip6fQ1k" title="Options outstanding weighted-average contractual life in years">8.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250101__20251231_zmgKGAKP5rjb" title="Options outstanding weighted-average contractual life in years">8.66</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted-average Exercise Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260630_zth4GuC554s5" style="text-align: right" title="Weighted-average exercise price exercisable">0.0743</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20250101__20251231_zw9B2bjx4FPf" style="text-align: right" title="Weighted-average exercise price exercisable">0.0663</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_892_ecustom--ScheduleOfShareBasedCompensationStockOptionsExercisableActivityTableTextBlock_zai2FFDgyrK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following table summarizes the stock options exercisable for the six months ended June 30, 2026, and the year ended December 31, 2025: SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Outstanding at the beginning of the period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20260101__20260630_zytfL2nttUQ2" style="width: 16%; text-align: right" title="Number of shares, exercisable">25,886,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20250101__20251231_zW1ixAeOAcW3" style="width: 16%; text-align: right" title="Number of shares, exercisable">15,649,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20260101__20260630_zL2QggZfvwm9" style="text-align: right" title="Number of shares vested">337,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20250101__20251231_zL1H4xRAMnv1" style="text-align: right" title="Number of shares vested">10,237,250</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20260101__20260630_zdTTQ5XspVqf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares Forfeited">(4,805,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20250101__20251231_zi6eH8O8nQLd" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares Forfeited">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Outstanding at the end of the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20260101__20260630_zzcBWCvejOmk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, exercisable">21,418,750</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20250101__20251231_zkp4HFqg9VJe" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, exercisable">25,886,250</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average contractual life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630_zvUOKnnTwUe3" title="Options exercisable weighted-average contractual life in years">8.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231_zbCkWsVGWCef" title="Options exercisable weighted-average contractual life in years">8.58</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted-average Exercise Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260630_zNstkjpIqEGf" title="Options exercisable weighted-average exercise price">0.0743</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20251231_zDaZu6nvDrJ2" title="Options exercisable weighted-average exercise price">0.0663</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Intrinsic value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table> The total intrinsic value of the options is zero because the closing stock price was below the weighted-average exercise price. <p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zf16GhrMpac6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following table summarizes certain information regarding the Company’s non-vested shares: SCHEDULE OF NON-VESTED SHARES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Non-vested as of December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20260101__20260630_zdCf5PG6OFFe" style="width: 16%; text-align: right" title="Number of shares, non-vested beginning balance">818,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantsInPeriodGross_c20260101__20260630_zMUZ2UxU8ssi" style="text-align: right" title="Number of shares granted">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forfeited or expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedOrExpiredNumberOfShares_iN_di_c20260101__20260630_zaXzY1gvF173" style="text-align: right" title="Number of shares forfeited or expired">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20260101__20260630_zJGRPrk0fbS4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares vested">(337,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Non-vested as of June 30, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20260101__20260630_znVCdhzWO5sl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, non-vested ending balance">481,250</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table> The Company recognized compensation costs of $1,029 and $177,757 for the three months ended June 30, 2026, and June 30, 2025. And $2,036 and $218,644 for the six months ended June 30, 2026, and June 30, 2025, respectively. There were $2,935 and $0 of unrecognized compensation costs for the six months ended June 30, 2026, and June 30, 2025, respectively. The cost is related to non-vested share options, which we will realize over the next two months.

25000000

0.001

2000

1200

Each share of the Series C Convertible Preferred Stock can be converted at any time after issuance, at the Holder’s option, into shares of Common Stock (subject to Beneficial Ownership Limitations), determined by dividing the Stated Value of $1,200 per share by the Conversion Price of $0.3202.

1200

0.3202

120

144000

783

3000000000

0.01

17698338

144000

14270720

30000

72742222

130640

250331008

177588785

<p id="xdx_89F_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zpG6drsNgD6l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">A summary of activity during the six months ended June 30, 2026, follows: SUMMARY OF WARRANTS ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Warrants Outstanding</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="padding-bottom: 1pt; text-align: center">Weighted Average</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center">Number of</td><td> </td><td> </td> <td colspan="2" style="text-align: center">Weighted Average</td><td> </td><td> </td> <td colspan="2" style="text-align: center"> Remaining life</td><td> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Warrants</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Exercise Price</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">(years)</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding, December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20260101__20260630_zPFZZmxMvBGe" style="width: 12%; text-align: right" title="Number of warrants outstanding beginning balance">2,538,101</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20260101__20260630_ze6bNzggElX3" style="width: 12%; text-align: right" title="Weighted average exercise price, outstanding beginning balance">0.3160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1_dtY_c20240101__20241231_zWsAnc8UVrfj" title="Weighted average remaining life (years)">1.24</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20260101__20260630_zPwaOx7JXxx7" style="text-align: right" title="Number of warrants, granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630_zcapSex1KdY7" style="text-align: right" title="Weighted average exercise price, outstanding granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Exercised</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20260101__20260630_zzZzU5M1pezd" style="text-align: right" title="Number of warrants, exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630_zX1XgX5doaD6" style="text-align: right" title="Weighted average exercise price, outstanding exercised">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Forfeited/canceled</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20260101__20260630_zeoS4sQlTzq7" style="border-bottom: Black 1pt solid; text-align: right" title="Number of warrants, forfeited/canceled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_pid_c20260101__20260630_zqe1LtpM53Ll" style="border-bottom: Black 1pt solid; text-align: right" title="Weighted average exercise price, outstanding forfeited/canceled">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Outstanding, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20260101__20260630_zFgbrwel8bfh" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants outstanding ending balance">2,538,101</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20260101__20260630_zVBDACohOJs7" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, outstanding ending balance">0.3160</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260630_zCYyTxhzblre" title="Weighted average remaining life (years)">0.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Exercisable Warrants, June 30, 2026</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber_iE_c20260101__20260630_zc5me2aNBeHi" style="border-bottom: Black 2.5pt double; text-align: right" title="Number of warrants, exercisable">2,538,101</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260630_zTk5WsDdlw11" style="border-bottom: Black 2.5pt double; text-align: right" title="Weighted average exercise price, exercisable">0.3160</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630_zgxEHbWK5Pw3" title="Weighted average remaining life (years) exercisable warrants">0.73</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2538101

0.3160 P1Y2M26D

2538101

0.3160 P0Y8M23D 2538101 0.3160 P0Y8M23D <p id="xdx_89C_ecustom--SummaryOfInformationRelatingToOutstandingAndExercisableWarrantsTableTextBlock_zVigFYpO7kz6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following table summarizes information relating to outstanding and exercisable warrants as of June 30, 2026: SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Number of Warrants</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Weighted Average Remaining Contractual life (in years)</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif">Weighted Average Exercise Price</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOneMember_zB0NP4BRj6Hh" style="font: 10pt Times New Roman, Times, Serif; width: 31%; text-align: right" title="Number of warrants, outstanding">941,599</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOneMember_z7IdOB4KQYc2" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.25</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%">$</td> <td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsOneMember_z8A3EfvgAaLd" style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.3404</td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsTwoMember_zjZwNZA3PqUh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">472,205</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsTwoMember_ziphh5Tt1hHk" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.12</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsTwoMember_zWyhSpEcbXEg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.3404</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsThreeMember_zhPM2TdNUmAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">562,149</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsThreeMember_zlUheCifFY49" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.17</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsThreeMember_zFYRJUBCiJne" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.3503</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFourMember_zH28zXF5ldwf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">281,074</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFourMember_zf7uotwZuE9l" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.09</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFourMember_znNec0QvI9q6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.2170</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFiveMember_zRhFoYex4wC4" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">281,074</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFiveMember_zRSHj0sJMbqe" title="Weighted Average Remaining life Contractual life (years), Warrants Outstanding">0.10</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630__us-gaap--ClassOfWarrantOrRightAxis__custom--WarrantsFiveMember_zRZfX05T9lu" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Exercise Price, Warrants Outstanding">0.2236</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20260630_zXZKJAxmuV5d" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants, outstanding">2,538,101</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm_dtY_c20260101__20260630_zxmpuR98gQh" title="Weighted average remaining life contractual life (years), warrants outstanding">0.73</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif">$</td> <td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iI_pid_c20260630_zHq56E6EiTff" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, warrants outstanding">0.3160</td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> </table>

941599

P0Y3M 0.3404

472205

P0Y1M13D 0.3404

562149

P0Y2M1D 0.3503

281074

P0Y1M2D 0.2170

281074

P0Y1M6D 0.2236

2538101

P0Y8M23D 0.3160

28400000

1395000

30000000 Our general policy for granting stock options is that a portion of the options vests after 90 days of service, with the remainder vesting incrementally over the next two years. The maximum validity period for the options is ten years. 3360000 2750000 500000

840000

1000000

1500000

2250000

200000

4805000

<p id="xdx_898_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_zW8vTfgdzbge" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white">SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__srt--RangeAxis__srt--MinimumMember_z16iqRz4vJli" title="Expected life in years">6.76 – <span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20260101__20260630__srt--RangeAxis__srt--MaximumMember_zLt3Q1pPIOX3" title="Expected life in years">9.39</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20251231__srt--RangeAxis__srt--MinimumMember_zRl2wJ1whYve" title="Expected life in years">7.25 – <span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20250101__20251231__srt--RangeAxis__srt--MaximumMember_z0yr58qtvFtj" title="Expected life in years">9.88</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 60%; text-align: left">Risk-free interest rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20260101__20260630_zAcjQV4LDX3k" title="Risk-free interest rate">4.31</td><td style="width: 1%; text-align: left">%</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 16%; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_pid_dp_uPure_c20250101__20251231_zOHf3N6E0aY6" title="Risk-free interest rate">4.29</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Annual forfeiture rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">192</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">252</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">0</td><td style="text-align: left">%</td></tr> </table>

P6Y9M3D

P9Y4M20D

P7Y3M

P9Y10M17D

0.0431

0.0429

0.26 0.10

1.92

2.52

<p id="xdx_898_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zDj5antZdHL7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following table summarizes the stock options activity for the six months ended June 30, 2026, and the year ended December 31, 2025: SUMMARY OF STOCK OPTION ACTIVITY <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Outstanding at the beginning of the period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20260101__20260630_zXOjjXoewlL2" style="width: 16%; text-align: right" title="Number of shares, outstanding beginning balance">26,705,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20250101__20251231_z2XwWWeopTQf" style="width: 16%; text-align: right" title="Number of shares, outstanding beginning balance">17,380,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20260101__20260630_z9flwwndgbc4" style="text-align: right" title="Number of shares outstanding, granted">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20250101__20251231_zw6MfFDjZWs5" style="text-align: right" title="Number of shares outstanding, granted">11,560,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_iN_pid_di_c20260101__20260630_zMoCeawjzRe5" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares outstanding, forfeited">(4,805,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_iN_pid_di_c20250101__20251231_zytWOljSU6Hg" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares outstanding, forfeited">(2,235,000</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Outstanding at the end of the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20260101__20260630_zCbbcOVPDXAb" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, outstanding ending balance">21,900,000</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20250101__20251231_zlW2xchigSQi" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, outstanding ending balance">26,705,000</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average contractual life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20260101__20260630_zU8b6ip6fQ1k" title="Options outstanding weighted-average contractual life in years">8.10</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_dtY_c20250101__20251231_zmgKGAKP5rjb" title="Options outstanding weighted-average contractual life in years">8.66</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted-average Exercise Price</td><td> </td> <td style="text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20260101__20260630_zth4GuC554s5" style="text-align: right" title="Weighted-average exercise price exercisable">0.0743</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20250101__20251231_zw9B2bjx4FPf" style="text-align: right" title="Weighted-average exercise price exercisable">0.0663</td><td style="text-align: left"> </td></tr> </table>

26705000

17380000

11560000

4805000

2235000

21900000

26705000

P8Y1M6D

P8Y7M28D

0.0743

0.0663

<p id="xdx_892_ecustom--ScheduleOfShareBasedCompensationStockOptionsExercisableActivityTableTextBlock_zai2FFDgyrK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following table summarizes the stock options exercisable for the six months ended June 30, 2026, and the year ended December 31, 2025: SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2026</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year Ended December 31, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Outstanding at the beginning of the period</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20260101__20260630_zytfL2nttUQ2" style="width: 16%; text-align: right" title="Number of shares, exercisable">25,886,250</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iS_pid_c20250101__20251231_zW1ixAeOAcW3" style="width: 16%; text-align: right" title="Number of shares, exercisable">15,649,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Vested</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20260101__20260630_zL2QggZfvwm9" style="text-align: right" title="Number of shares vested">337,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20250101__20251231_zL1H4xRAMnv1" style="text-align: right" title="Number of shares vested">10,237,250</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Forfeited</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20260101__20260630_zdTTQ5XspVqf" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares Forfeited">(4,805,000</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_981_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_iN_di_c20250101__20251231_zi6eH8O8nQLd" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares Forfeited">-</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Outstanding at the end of the period</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20260101__20260630_zzcBWCvejOmk" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, exercisable">21,418,750</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20250101__20251231_zkp4HFqg9VJe" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, exercisable">25,886,250</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Weighted-average contractual life in years</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20260101__20260630_zvUOKnnTwUe3" title="Options exercisable weighted-average contractual life in years">8.09</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20250101__20251231_zbCkWsVGWCef" title="Options exercisable weighted-average contractual life in years">8.58</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Weighted-average Exercise Price</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20260630_zNstkjpIqEGf" title="Options exercisable weighted-average exercise price">0.0743</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_c20251231_zDaZu6nvDrJ2" title="Options exercisable weighted-average exercise price">0.0663</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Intrinsic value</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> </table>

25886250

15649000

337500

10237250

4805000

21418750

25886250

P8Y1M2D

P8Y6M29D

0.0743

0.0663

<p id="xdx_897_eus-gaap--ScheduleOfNonvestedShareActivityTableTextBlock_zf16GhrMpac6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The following table summarizes certain information regarding the Company’s non-vested shares: SCHEDULE OF NON-VESTED SHARES <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%">Non-vested as of December 31, 2025</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iS_c20260101__20260630_zdCf5PG6OFFe" style="width: 16%; text-align: right" title="Number of shares, non-vested beginning balance">818,750</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Granted</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantsInPeriodGross_c20260101__20260630_zMUZ2UxU8ssi" style="text-align: right" title="Number of shares granted">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Forfeited or expired</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedOrExpiredNumberOfShares_iN_di_c20260101__20260630_zaXzY1gvF173" style="text-align: right" title="Number of shares forfeited or expired">-</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt">Vested</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_iN_di_c20260101__20260630_zJGRPrk0fbS4" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares vested">(337,500</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt">Non-vested as of June 30, 2026</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iE_c20260101__20260630_znVCdhzWO5sl" style="border-bottom: Black 1pt solid; text-align: right" title="Number of shares, non-vested ending balance">481,250</td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> </table>

818750

337500

481250

1029

177757

2036

218644

2935

NOTE 14 - COMMITMENTS AND CONTINGENCIES Employment Agreements Stephen Morris, Founder, Chief Executive Officer, and Director On December 31, 2023, the Company entered into a Second Amended Employment Agreement with Stephen Morris to reduce his base pay from $<span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeit_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SecondAmendedEmploymentAgreementMember__us-gaap--OtherCommitmentsAxis__custom--StephenMorrisMember__srt--RangeAxis__srt--MaximumMember_zgXD0MlWG8mj" title="Annual payment">450,000 to $<span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeit_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SecondAmendedEmploymentAgreementMember__us-gaap--OtherCommitmentsAxis__custom--StephenMorrisMember__srt--RangeAxis__srt--MinimumMember_zGt2VMy7c2B8" title="Annual payment">90,000 per annum and forfeit $<span id="xdx_900_ecustom--DeferredCompensation_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SecondAmendedEmploymentAgreementMember__us-gaap--OtherCommitmentsAxis__custom--StephenMorrisMember_zXXwILSvR656" title="Deferred compensation">270,000 of deferred compensation. Payments are withheld until the Company secures $<span id="xdx_909_eus-gaap--SecuredDebt_iI_pn6n6_c20231231__us-gaap--TypeOfArrangementAxis__custom--SecondAmendedEmploymentAgreementMember__us-gaap--OtherCommitmentsAxis__custom--StephenMorrisMember_zzTER5TjrEge" title="Monthly salaries payments">2 million in funding. David Chetwood, Chief Financial Officer and Director On December 31, 2023, the Company entered into a Second Amended Employment Agreement with David Chetwood to reduce his base pay from $<span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeit_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SecondAmendedEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember__us-gaap--OtherCommitmentsAxis__custom--DavidChetwoodMember_zVHEfE115jRk" title="Annual payment">450,000 to $<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeit_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--SecondAmendedEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember__us-gaap--OtherCommitmentsAxis__custom--DavidChetwoodMember_zZokNnCb2Fn7" title="Annual payment">180,000 per annum and forfeit $<span id="xdx_907_ecustom--DeferredCompensation_c20230101__20231231__us-gaap--OtherCommitmentsAxis__custom--DavidChetwoodMember__us-gaap--TypeOfArrangementAxis__custom--SecondAmendedEmploymentAgreementMember_z3tgbSXmBtNl" title="Deferred compensation">236,200 of deferred compensation. On October 17, 2024, the Company entered into a Third Amended Employment Agreement with David Chetwood, reducing his base pay from $<span id="xdx_90D_ecustom--AnnualSalary_iI_c20241017__us-gaap--TypeOfArrangementAxis__custom--ThirdAmendedEmploymentAgreementMember__srt--RangeAxis__srt--MaximumMember__srt--TitleOfIndividualAxis__custom--DavidChetwoodMember_zkaiVe9DGtE9" title="Annual base salary">180,000 to $<span id="xdx_900_ecustom--AnnualSalary_iI_c20241017__us-gaap--TypeOfArrangementAxis__custom--ThirdAmendedEmploymentAgreementMember__srt--RangeAxis__srt--MinimumMember__srt--TitleOfIndividualAxis__custom--DavidChetwoodMember_zqKSzLomdrK4" title="Annual base salary">90,000 per annum. Payments are withheld until the Company secures $<span id="xdx_906_eus-gaap--SecuredDebt_iI_pn6n6_c20241017__us-gaap--TypeOfArrangementAxis__custom--ThirdAmendedEmploymentAgreementMember__srt--TitleOfIndividualAxis__custom--DavidChetwoodMember_z8DjtJNoEIJ5" title="Monthly salaries payments">2 million in funding. Patrick Ensor, Chief Revenue Officer and Director On August 5, 2025, the Company entered into an Employment Agreement with Mr. Patrick Ensor, which provides him with an annual salary of $<span id="xdx_905_eus-gaap--SalariesWagesAndOfficersCompensation_c20250805__20250805__srt--TitleOfIndividualAxis__custom--MrPatrickEnsorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zG983A0QWnie" title="Annual salary">90,000, payable in monthly installments. Payments will be $<span id="xdx_909_eus-gaap--SalariesAndWages_c20250805__20250805__srt--TitleOfIndividualAxis__custom--MrPatrickEnsorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_z4CcrFoDB8p1" title="Monthly salaries payments">3,750 per month, representing a half-rate reduction, until the Company secures $<span id="xdx_909_eus-gaap--SecuredDebt_iI_pn6n6_c20250805__srt--TitleOfIndividualAxis__custom--MrPatrickEnsorMember__us-gaap--TypeOfArrangementAxis__custom--EmploymentAgreementMember_zOGLYzkUhSFj" title="Monthly salaries payments">2 million in funding. Manfred Ebensberger, Former Chief Executive Officer and Director On October 17, 2024, the Company entered into an Executive Consulting Agreement with Manfred Ebensberger, Former Chief Executive Officer, under which he is paid $<span id="xdx_903_eus-gaap--SalariesWagesAndOfficersCompensation_c20241017__20241017__srt--TitleOfIndividualAxis__custom--ManfredEbensbergerMember__us-gaap--TypeOfArrangementAxis__custom--ExecutiveConsultingAgreementMember_zNl7KMiiG7M4" title="Annual salary">90,000 annually. Payments are withheld until the Company secures $<span id="xdx_90E_eus-gaap--SecuredDebt_iI_pn6n6_c20241017__srt--TitleOfIndividualAxis__custom--ManfredEbensbergerMember__us-gaap--TypeOfArrangementAxis__custom--ExecutiveConsultingAgreementMember_z3SHMZgIkoy5" title="Monthly salaries payments">2 million in funding. Mr. Ebensberger resigned on January 14, 2025. Tom Symonds, Former Chief Executive Officer and Director On January 15, 2025, the Company entered into an Executive Employment Agreement with Tom Symonds, Former Chief Executive Officer, under which he is paid an annual salary of $<span id="xdx_909_eus-gaap--SalariesWagesAndOfficersCompensation_c20250115__20250115__srt--TitleOfIndividualAxis__custom--TomSymondsMember__us-gaap--TypeOfArrangementAxis__custom--ExecutiveConsultingAgreementMember_zEd63ioWnkx2" title="Annual salary">90,000. Payments are withheld until the Company secures $2 million in funding. Mr. Symonds resigned on June 11, 2025. We may occasionally become involved in various claims and legal proceedings that are considered normal and incidental to our business. These might include product liability, intellectual property, employment issues, personal injury claims from our employees’ actions, and other general claims. Regardless of the outcome, litigation can adversely affect us, including increased defense costs and settlements, diversion of management resources, and other impacts. As of June 30, 2026, the Company has not accrued any liabilities for loss contingencies, as no outstanding claims are deemed probable and reasonably estimable under ASC 450.

450000 90000 270000

2000000

450000 180000 236200 180000 90000

2000000

90000

3750

2000000

90000

2000000

90000

NOTE 15 - SUBSEQUENT EVENTS The Company evaluated subsequent events through August 21, 2026, the date the consolidated financial statements were available for issuance. Management determined that no subsequent events require recognition or disclosure, except as described below. On July 2, 2026, the Company issued <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260702__20260702__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zC5DkqZopDci">11,265,313 shares of common stock upon the conversion of certain outstanding convertible promissory notes with an aggregate principal and interest value of $8,111. Concurrently, on July 2, 2026, the Company issued 12,000,000 shares of common stock upon the conversion of certain outstanding convertible promissory notes with an aggregate principal value of $5,880. On July 6, 2026, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20260706__20260706__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zcBjvT0NNyl3" title="Shares issued for conversion">4,202,295 shares of common stock upon the conversion of certain outstanding convertible promissory notes with an aggregate principal and interest value of $3,026, with the associated par value deficit similarly absorbed within additional paid-in capital. On July 22, 2026, the Company issued <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260722__20260722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zdjcireBKTP8" title="Stock issued during the period, shares">13,000,000 shares of common stock upon the conversion of certain outstanding convertible promissory notes with an aggregate principal value of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260722__20260722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteMember_zyR5QpgzEUSk" title="Stock issued during the period, Value">5,551. On July 22, 2026, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20260722__20260722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteOneMember_zjOE0C2QIXH2" title="Stock issued during the period, shares">14,510,539 shares of common stock upon the conversion of certain outstanding convertible promissory notes with an aggregate principal and interest value of $<span id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20260722__20260722__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--PromissoryNoteOneMember_zejfw3LJBGxj" title="Stock issued during the period, Value">6,196.

11265313

8111

12000000

5880

4202295

3026

13000000

5551

14510539

6196